Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in Brain Res Retrieve available abstracts of 146 articles: HTML format

Single Articles

October 2025
1. BI D, Gao B, Shen Y, Dai Z, et al
   Traumatic brain injury and neurodegenerative diseases: the role of axonal injury and amyloid-beta.
   Brain Res. 2025;1865:149873.
   PubMed     Abstract available
   
   
   
2. DING Z, Wang J, Ding W, Duan Y, et al
   Calycosin improved long-term memory impairment in the very early of APP/PS1 mice.
   Brain Res. 2025;1864:149789.
   PubMed     Abstract available
   
   
   
3. GENG D, Liu A, Yan Y, Zheng W, et al
   Intermittent ELF-MF exposure effectively ameliorates pathologic features associated with adult AD mice.
   Brain Res. 2025;1864:149796.
   PubMed     Abstract available
   
   
   September 2025
4. AKASH A, Ahamed M, Porel P, Aran KR, et al
   Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications.
   Brain Res. 2025 Sep 19:149949. doi: 10.1016/j.brainres.2025.149949.
   PubMed     Abstract available
   
   
   
5. HU X, Morihara R, Fukui Y, Bian Y, et al
   Spearmint extract Neumentix downregulates amyloid-beta accumulation by promoting phagocytosis in APP23 mice.
   Brain Res. 2025;1863:149752.
   PubMed     Abstract available
   
   
   
6. SHENG J, Zhu H, Zhou R, Zhang Q, et al
   Bridging the gap between structural and metabolic neuroimaging via MRI-to-PET synthesis: A tri-attention enhanced GAN approach.
   Brain Res. 2025;1862:149691.
   PubMed     Abstract available
   
   
   August 2025
7. CAM OZUNLU SA, Uysal F, Tatli Dogan H, Parlar A, et al
   Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model of Alzheimer's disease.
   Brain Res. 2025;1866:149918.
   PubMed     Abstract available
   
   
   
8. LI J, Wang C, Zhang JH, Cai JM, et al
   Expression of concern: "Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress" [BRAIN RES, Volume 1328 (2010) 152-161].
   Brain Res. 2025;1861:149685.
   PubMed    
   
   
   
9. MOHAN M, Mannan A, Singh S, Singh TG, et al
   Unlocking the cellular mystery: how proton pump inhibitors may alter the dementia landscape.
   Brain Res. 2025;1861:149702.
   PubMed     Abstract available
   
   
   
10. LIU B, Ahmad MA, Abbas G, Ahmed U, et al
    From particulates to pathways: environmental exposures and their impact on Alzheimer's disease.
    Brain Res. 2025 Aug 8:149880. doi: 10.1016/j.brainres.2025.149880.
    PubMed     Abstract available
    
    
    
11. LIU L, Jiang M, Zhang Y, Lv L, et al
    Acori Tatarinowii Rhizoma inhibited neuroinflammation in Alzheimer's disease rats by modulating the intestinal flora.
    Brain Res. 2025 Aug 8:149878. doi: 10.1016/j.brainres.2025.149878.
    PubMed     Abstract available
    
    
    July 2025
12. ALOUANI Z, Gannour OE, Saleh S, El-Ibrahimi A, et al
    A novel contrastive Dual-Branch Network (CDB-Net) for robust EEG-Based Alzheimer's disease diagnosis.
    Brain Res. 2025;1865:149863.
    PubMed     Abstract available
    
    
    
13. WANG Y, Mu D, Li Y, Liu C, et al
    Alzheimer's disease: a jigsaw puzzle comprised of different types of programmed cell death pieces.
    Brain Res. 2025;1865:149861.
    PubMed     Abstract available
    
    
    
14. ISLAM MA, Kshirsagar S, Alvir RV, Pradeepkiran JA, et al
    Overexpressed MicroRNA-455-3p enhances cognitive function in late-onset Alzheimer's disease.
    Brain Res. 2025 Jul 21:149853. doi: 10.1016/j.brainres.2025.149853.
    PubMed     Abstract available
    
    
    
15. YAO M, Liu A, Song J, Xing L, et al
    The impact of epigenetic and epitranscriptomic modifications on Alzheimer's disease: the mysteries of DNA, RNA, and histone methylation.
    Brain Res. 2025;1865:149852.
    PubMed     Abstract available
    
    
    
16. SALGADO KDCB, Nascimento RGF, Albuquerque ALS, Oliveira LAM, et al
    Melatonin protects mouse hippocampal neurons from neurotoxicity induced by amyloid beta-peptide(25-35).
    Brain Res. 2025;1859:149637.
    PubMed     Abstract available
    
    
    
17. BASHIR DJ, Bhat KA, Bashir M
    Deciphering Alzheimer's disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier.
    Brain Res. 2025;1863:149828.
    PubMed     Abstract available
    
    
    
18. BALL BK, Kuhn MK, Fleeman Bechtel RM, Proctor EA, et al
    Metabolites associated with type 2 diabetes and Alzheimer's disease trigger differential intracellular signaling responses in mouse primary neurons.
    Brain Res. 2025;1864:149819.
    PubMed     Abstract available
    
    
    June 2025
19. HE J, Ran M, Tam KY
    An orally administered quinolinium molecule mitigates neuropathology of Alzheimer's disease through modulation of mitochondrial dysfunction and neuroinflammation.
    Brain Res. 2025 Jun 25:149804. doi: 10.1016/j.brainres.2025.149804.
    PubMed     Abstract available
    
    
    
20. MA XH, Dai H, Liu SY, Liu XN, et al
    Protection of dauricine and daurisoline on PC12 cells damaged by glutamate or Abeta(25-35).
    Brain Res. 2025;1857:149609.
    PubMed     Abstract available
    
    
    
21. KHAN G, Hussain MS, Khan Y, Fatima R, et al
    Ferroptosis and its contribution to cognitive impairment in Alzheimer's disease: mechanisms and therapeutic potential.
    Brain Res. 2025 Jun 9:149776. doi: 10.1016/j.brainres.2025.149776.
    PubMed     Abstract available
    
    
    May 2025
22. ARIOZ BI, Binokay L, Tastan B, Genc B, et al
    Characterization of tRNA-derived fragments in the small neuron-derived extracellular vesicles of Alzheimer's disease patients.
    Brain Res. 2025;1862:149730.
    PubMed     Abstract available
    
    
    
23. CHAVEZ-LOPEZ LM, Silvestre-Martinez JH, Del Carmen Lugo-Ibarra K, Castro-Cesena AB, et al
    A comprehensive approach to Alzheimer's Disease: Exploring Nanotechnology, treatment Innovations, and sex differences.
    Brain Res. 2025 May 26:149718. doi: 10.1016/j.brainres.2025.149718.
    PubMed     Abstract available
    
    
    
24. YANG X, Jiang M, Wu M, Jin X, et al
    Crocin drives intestinal microbiota variation in a rat model of Alzheimer's disease by reducing DKK3 expression.
    Brain Res. 2025;1862:149734.
    PubMed     Abstract available
    
    
    
25. ZHOU Q, Huang X, Chen Z, Wang F, et al
    Mechanism of Rhizoma Polygonati in the treatment of Alzheimer's disease based on network pharmacology and molecular docking.
    Brain Res. 2025 May 22:149680. doi: 10.1016/j.brainres.2025.149680.
    PubMed     Abstract available
    
    
    
26. SOLEIMANI Z, Davoudi S, Saffarzadeh F, Behzadi G, et al
    Restoring neuronal excitability and spatial memory through inhibiting amyloid-beta-induced hyperactive NF-kappaB in a rat model of Alzheimer's disease.
    Brain Res. 2025;1861:149703.
    PubMed     Abstract available
    
    
    
27. KAUR J, Sharma V, Khan H, Singh S, et al
    Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential.
    Brain Res. 2025;1855:149568.
    PubMed     Abstract available
    
    
    
28. SHAHID F, Khan R, Mehmood A, Smadi AA, et al
    A comprehensive approach to anticipating the progression of mild cognitive impairment.
    Brain Res. 2025;1855:149549.
    PubMed     Abstract available
    
    
    
29. XU C
    Enhanced social interaction protects cognition by preserving synapse numbers.
    Brain Res. 2025;1854:149552.
    PubMed     Abstract available
    
    
    April 2025
30. MIYAZAKI H, Ide K, Yamaguchi H, Ogawa M, et al
    Peripheral lymphocyte counts and regional cerebral blood flow on brain SPECT correlate in Alzheimer's disease: A retrospective cross-sectional study.
    Brain Res. 2025;1859:149657.
    PubMed     Abstract available
    
    
    
31. AHSAN R, Khan MM, Mishra A, Noor G, et al
    Plumbagin as a potential therapeutic agent for scopolamine-induced Alzheimer's disease: Mechanistic insights into GSK-3beta inhibition.
    Brain Res. 2025 Apr 16:149650. doi: 10.1016/j.brainres.2025.149650.
    PubMed     Abstract available
    
    
    
32. FANG L, Fu X, Yu Y, Liu D, et al
    Collaborative multitasking framework for enhanced hippocampus segmentation and Alzheimer's disease classification.
    Brain Res. 2025;1858:149610.
    PubMed     Abstract available
    
    
    
33. AKBARI F, Soheilian R, Tavalaeian S, Zamani A, et al
    Alterations in NFAT5 and ATP6V1E1 expression as potential diagnostic biomarkers in blood and brain for Alzheimer's disease: A study of gene overlap.
    Brain Res. 2025 Apr 3:149599. doi: 10.1016/j.brainres.2025.149599.
    PubMed     Abstract available
    
    
    
34. RADBAKHSH S, Abrego-Guandique DM, Bacchetti T, Aghaee-Bakhtiari SH, et al
    Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer's disease under intravenous trehalose treatment.
    Brain Res. 2025;1857:149607.
    PubMed     Abstract available
    
    
    
35. CHIANG MC, Nicol CJB, Yang YP, Chiang T, et al
    The alpha-MG exhibits neuroprotective potential by reducing amyloid beta peptide-induced inflammation, oxidative stress, and tau aggregation in human neural stem cells.
    Brain Res. 2025;1852:149506.
    PubMed     Abstract available
    
    
    March 2025
36. KARIM F, Ngo A, Danh TB, Delaney BA, et al
    Reduction in [(18)F]Nifene Binding, a PET imaging Probe for alpha4beta2* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer's disease brain.
    Brain Res. 2025;1857:149600.
    PubMed     Abstract available
    
    
    
37. KAZEMI M, Sanati M, Shekari Khaniani M, Ghafouri-Fard S, et al
    A review on the lncRNA-miRNA-mRNA regulatory networks involved in inflammatory processes in Alzheimer's disease.
    Brain Res. 2025;1856:149595.
    PubMed     Abstract available
    
    
    
38. JAIN S, Murmu A, Chauhan A
    Advancing Alzheimer's disease therapy through engineered exosomal Macromolecules.
    Brain Res. 2025;1855:149590.
    PubMed     Abstract available
    
    
    
39. PINKY, Anwar S, Neha, Parvez S, et al
    Paeoniflorin inhibits pyruvate dehydrogenase kinase 3 and promotes BDNF activity by modulating neuronal activity and TNF-alpha.
    Brain Res. 2025;1851:149476.
    PubMed     Abstract available
    
    
    
40. ABDEL-AAL RA, Meligy FY, Maghraby N, Sayed N, et al
    Comparing levetiracetam and zonisamide effects on rivastigmine anti-Alzheimer's activity in aluminum chloride-induced Alzheimer's-like disease in rats: Impact on alpha7 nicotinic acetylcholine receptors and amyloid beta.
    Brain Res. 2025;1855:149573.
    PubMed     Abstract available
    
    
    
41. ZHENG C, Zhao Y, Hu C, Zhang L, et al
    Transcriptomic and network analysis identifies shared pathways across Alzheimer's disease and vascular dementia.
    Brain Res. 2025 Mar 3:149548. doi: 10.1016/j.brainres.2025.149548.
    PubMed     Abstract available
    
    
    
42. DERAFSHPOUR L, Niazi M, Pourheydar B, Roshan-Milani S, et al
    Aging and voluntary exercise's effects on Abeta1-42 levels, endoplasmic reticulum stress factors, and apoptosis in the hippocampus of old male rats.
    Brain Res. 2025;1850:149447.
    PubMed     Abstract available
    
    
    
43. GUTIERRE RC, Rocha PR, Graciani AL, Coppi AA, et al
    Tau, amyloid, iron, oligodendrocytes ferroptosis, and inflammaging in the hippocampal formation of aged rats submitted to an aerobic exercise program.
    Brain Res. 2025;1850:149419.
    PubMed     Abstract available
    
    
    
44. WANG R, Azad AK, Sheikh AM, Tabassum S, et al
    Carboxylated Zn-phthalocyanine attenuates brain Abeta in AD model mouse.
    Brain Res. 2025;1850:149422.
    PubMed     Abstract available
    
    
    February 2025
45. GHADGE SR, Shimpi PH, Kumbhar VV, Khairnar B, et al
    Comprehensive evaluation of AChE inhibition by Eulophia ochreata extract Utilizing in Silico, ex Vivo, and in vivo zebrafish models.
    Brain Res. 2025 Feb 24:149531. doi: 10.1016/j.brainres.2025.149531.
    PubMed     Abstract available
    
    
    
46. TIAN Y, Li W, Zhang Y
    3-N-Butylphthalide alleviate Abeta-induced cellular senescence through the CDK2-pRB1-Caspase3 axis.
    Brain Res. 2025;1849:149435.
    PubMed     Abstract available
    
    
    
47. WANG L, Li W, Wu W, Liu Q, et al
    Effects of electroacupuncture on microglia phenotype and epigenetic modulation of C/EBPbeta in SAMP8 mice.
    Brain Res. 2025;1849:149339.
    PubMed     Abstract available
    
    
    
48. ZHAO X, Zhou Q, Zhang H, Ono M, et al
    Olfactory deprivation promotes amyloid beta deposition in a mouse model of Alzheimer's disease.
    Brain Res. 2025;1851:149500.
    PubMed     Abstract available
    
    
    
49. DHAPOLA R, Kumari S, Sharma P, Vellingiri B, et al
    Advancements in autophagy perturbations in Alzheimer's disease: Molecular aspects and therapeutics.
    Brain Res. 2025;1851:149494.
    PubMed     Abstract available
    
    
    January 2025
50. LI W, Yong-Yan X, Jia-Xin M, Shu-Chao G, et al
    Senescent microglia: The hidden culprits accelerating Alzheimer's disease.
    Brain Res. 2025 Jan 28:149480. doi: 10.1016/j.brainres.2025.149480.
    PubMed     Abstract available
    
    
    
51. CHIARINI A, Armato U, Gui L, Yin M, et al
    Early divergent modulation of NLRP2's and NLRP3's inflammasome sensors vs. AIM2's one by signals from Abeta.Calcium-sensing receptor complexes in human astrocytes.
    Brain Res. 2025;1846:149283.
    PubMed     Abstract available
    
    
    December 2024
52. ZHANG Z, Zhang S, Liu S, He Y, et al
    Fuzhisan ameliorates cognitive ability in Alzheimer's disease by p62 and related autophagy regulatory pathways.
    Brain Res. 2024;1849:149436.
    PubMed     Abstract available
    
    
    
53. YANG Q, Chen T, Li S, Yang C, et al
    Inhibition of autophagy attenuates cognitive decline and mitochondrial dysfunction in an Alzheimer's disease mouse model with chronic cerebral hypoperfusion.
    Brain Res. 2024;1850:149416.
    PubMed     Abstract available
    
    
    
54. XIE Y, Yang M, Wang H, Chen Y, et al
    Potential molecular mechanisms of tobacco smoke exposure in Alzheimer's disease.
    Brain Res. 2024;1848:149394.
    PubMed     Abstract available
    
    
    
55. CHEN J, Zhang M, Shen Z, Tang M, et al
    Low-dose diazepam improves cognitive function in APP/PS1 mouse models: Involvement of AMPA receptors.
    Brain Res. 2024;1845:149207.
    PubMed     Abstract available
    
    
    
56. DE SOUSA RAL, Mendes BF
    T-regulatory cells and extracellular vesicles in Alzheimer's disease: New therapeutic concepts and hypotheses.
    Brain Res. 2024;1850:149393.
    PubMed     Abstract available
    
    
    
57. SUN S, Cui C, Li Y, Meng Y, et al
    A Machine learning classification framework using fused fractal property feature vectors for Alzheimer's disease diagnosis.
    Brain Res. 2024 Dec 3:149373. doi: 10.1016/j.brainres.2024.149373.
    PubMed     Abstract available
    
    
    November 2024
58. CHEN Z, Zheng N, Wang F, Zhou Q, et al
    The role of ferritinophagy and ferroptosis in Alzheimer's disease.
    Brain Res. 2024 Nov 23:149340. doi: 10.1016/j.brainres.2024.149340.
    PubMed     Abstract available
    
    
    
59. LIN L, Li J, Yu Z, He J, et al
    Nrf2 activator tertiary butylhydroquinone enhances neural stem cell differentiation and implantation in Alzheimer's disease by boosting mitochondrial function.
    Brain Res. 2024 Nov 18:149341. doi: 10.1016/j.brainres.2024.149341.
    PubMed     Abstract available
    
    
    
60. PATTANAIK S, Prusty SK, Sahu PK
    Exploring DPP IV inhibitors for Alzheimer's disease: Bridging diabetes and neurodegeneration.
    Brain Res. 2024 Nov 18:149342. doi: 10.1016/j.brainres.2024.149342.
    PubMed     Abstract available
    
    
    
61. MAHMUD JOY MA, Nasrin S, Siddiqua A, Farid DM, et al
    ViTAD: Leveraging Modified Vision Transformer for Alzheimer's Disease Multi-Stage Classification from Brain MRI Scans.
    Brain Res. 2024 Nov 11:149302. doi: 10.1016/j.brainres.2024.149302.
    PubMed     Abstract available
    
    
    
62. ZHANG T, Yang J, Xu H, Cao Y, et al
    Acorus tatarinowii alleviates D-galactose-induced Alzheimer's-like disease cognitive impairment and Abeta-induced pericytes dysfunction in mice.
    Brain Res. 2024 Nov 6:149312. doi: 10.1016/j.brainres.2024.149312.
    PubMed     Abstract available
    
    
    
63. DING X, Liu F, Wang H, Wang Y, et al
    Ganoderic acid a decreased Abeta42-induced neurotoxicity in PC12 cells by reduced mitochondrial damage.
    Brain Res. 2024;1842:149102.
    PubMed     Abstract available
    
    
    
64. DIVYA R, Shantha Selva Kumari R
    Multi-instance learning attention model for amyloid quantification of brain sub regions in longitudinal cognitive decline.
    Brain Res. 2024;1842:149103.
    PubMed     Abstract available
    
    
    October 2024
65. SEREBROVSKA Z, Xi L, Fedoriuk M, Dosenko V, et al
    Intermittent hypoxia-hyperoxia training ameliorates cognitive impairment and neuroinflammation in a rat model of Alzheimer's disease.
    Brain Res. 2024 Oct 28:149301. doi: 10.1016/j.brainres.2024.149301.
    PubMed     Abstract available
    
    
    
66. GANESH A, Choudhury W, Coutellier L
    Early spatial recognition memory deficits in 5XFAD female mice are associated with disruption of prefrontal parvalbumin neurons.
    Brain Res. 2024;1841:149122.
    PubMed     Abstract available
    
    
    
67. XIA N, Xu L, Xu D, Huang M, et al
    Neuroprotective effect of emodin on Abeta(25-35)-induced cytotoxicity in PC12 cells involves Nrf2/GPX4 and TLR4/p-NF-kappaB/NLRP3 pathways.
    Brain Res. 2024;1841:149019.
    PubMed     Abstract available
    
    
    
68. MAFTOON H, Davar Siadat S, Tarashi S, Soroush E, et al
    Ameliorative effects of Akkermansia muciniphila on anxiety-like behavior and cognitive deficits in a rat model of Alzheimer's disease.
    Brain Res. 2024 Oct 15:149280. doi: 10.1016/j.brainres.2024.149280.
    PubMed     Abstract available
    
    
    
69. PARKER J, Moris JM, Goodman LC, Paidisetty VK, et al
    A multifactorial lens on risk factors promoting the progression of Alzheimer's disease.
    Brain Res. 2024;1846:149262.
    PubMed     Abstract available
    
    
    September 2024
70. ASADIFARD E, Hokmabadi M, Hashemi M, Bereimipour A, et al
    Linking gut microbiota dysbiosis to molecular pathways in Alzheimer's disease.
    Brain Res. 2024 Sep 16:149242. doi: 10.1016/j.brainres.2024.149242.
    PubMed     Abstract available
    
    
    
71. WANG W, Xia H
    The role of lipid species in Alzheimer's disease onset: A comprehensive Mendelian randomization analysis.
    Brain Res. 2024 Sep 13:149238. doi: 10.1016/j.brainres.2024.149238.
    PubMed     Abstract available
    
    
    
72. HAN R, Zhang X, Chen Y, Hou X, et al
    Associations between differential connectivity patterns of executive control networks and APOE varepsilon4 in the Alzheimer continuum.
    Brain Res. 2024 Sep 8:149229. doi: 10.1016/j.brainres.2024.149229.
    PubMed     Abstract available
    
    
    August 2024
73. THAPA R, Ahmad Bhat A, Shahwan M, Ali H, et al
    Proteostasis disruption and senescence in Alzheimer's disease pathways to neurodegeneration.
    Brain Res. 2024;1845:149202.
    PubMed     Abstract available
    
    
    
74. ZHANG QX, Zhang LJ, Zhao N, Yang L, et al
    Irisin in ischemic Stroke, Alzheimer's disease and Depression: A narrative review.
    Brain Res. 2024 Aug 28:149192. doi: 10.1016/j.brainres.2024.149192.
    PubMed     Abstract available
    
    
    
75. SINGH M, Ali H, Renuka Jyothi S, Kaur I, et al
    Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer's disease.
    Brain Res. 2024;1844:149165.
    PubMed     Abstract available
    
    
    
76. ZHONG F, Xiong L, Wu J, Chen Y, et al
    The KEAP1/PGAM5/AIFM1-Mediated oxeiptosis pathway in Alzheimer's disease.
    Brain Res. 2024 Aug 19:149173. doi: 10.1016/j.brainres.2024.149173.
    PubMed     Abstract available
    
    
    
77. BREEZE B, Connell E, Wileman T, Muller M, et al
    Menopause and Alzheimer's disease susceptibility: Exploring the potential mechanisms.
    Brain Res. 2024 Aug 18:149170. doi: 10.1016/j.brainres.2024.149170.
    PubMed     Abstract available
    
    
    
78. MCCLARTY BM, Rodriguez G, Dong H
    Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP/PS1 mice.
    Brain Res. 2024;1837:148951.
    PubMed     Abstract available
    
    
    July 2024
79. SMITH T, Knudsen KJ, Ritchie SA
    A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer's disease.
    Brain Res. 2024 Jul 23:149132. doi: 10.1016/j.brainres.2024.149132.
    PubMed     Abstract available
    
    
    
80. ABUDUAINI Y, Chen W, Kong XZ
    Handedness in Alzheimer's disease: A systematic review.
    Brain Res. 2024 Jul 23:149131. doi: 10.1016/j.brainres.2024.149131.
    PubMed     Abstract available
    
    
    June 2024
81. SUN S, Lu W, Zhang C, Wang G, et al
    Folic acid and S-adenosylmethionine reverse Homocysteine-induced Alzheimer's disease-like pathological changes in rat hippocampus by modulating PS1 and PP2A methylation levels.
    Brain Res. 2024 Jun 23:149095. doi: 10.1016/j.brainres.2024.149095.
    PubMed     Abstract available
    
    
    
82. DE LOURDES SIGNORINI-SOUZA I, Tureck LV, Batistela MS, Coutinho de Almeida R, et al
    The potential of five c-miRNAs as serum biomarkers for Late-Onset Alzheimer's disease diagnosis: miR-10a-5p, miR-29b-2-5p, miR-125a-5p, miR-342-3p, and miR-708-5p.
    Brain Res. 2024 Jun 14:149090. doi: 10.1016/j.brainres.2024.149090.
    PubMed     Abstract available
    
    
    
83. RUSSO ML, Ayala G, Neal D, Rogalsky AE, et al
    Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice.
    Brain Res. 2024 Jun 10:149083. doi: 10.1016/j.brainres.2024.149083.
    PubMed     Abstract available
    
    
    
84. WANG Y, Wu LH, Hou F, Wang ZJ, et al
    Mitochondrial calcium uniporter knockdown in hippocampal neurons alleviates anxious and depressive behavior in the 3XTG Alzheimer's disease mouse model.
    Brain Res. 2024 Jun 6:149060. doi: 10.1016/j.brainres.2024.149060.
    PubMed     Abstract available
    
    
    May 2024
85. FARHATULLAH, Chen X, Zeng D, Mehmood A, et al
    3-Way hybrid analysis using clinical and magnetic resonance imaging for early diagnosis of Alzheimer's disease.
    Brain Res. 2024 May 27:149021. doi: 10.1016/j.brainres.2024.149021.
    PubMed     Abstract available
    
    
    
86. BHADANE P, Roul K, Belemkar S, Kumar D, et al
    Immunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress.
    Brain Res. 2024 May 21:149018. doi: 10.1016/j.brainres.2024.149018.
    PubMed     Abstract available
    
    
    
87. ZHOU Q, Xu L
    The regulation of BAI1 in astrocytes through the STAT3/EZH2 axis relieves neuronal apoptosis in rats with Alzheimer's disease.
    Brain Res. 2024;1839:149007.
    PubMed     Abstract available
    
    
    
88. LIU X, Chen J, Du Y, Tian Q, et al
    The changes of neurogenesis in the hippocampal dentate gyrus of SAMP8 mice and the effects of acupuncture and moxibustion.
    Brain Res. 2024;1831:148814.
    PubMed     Abstract available
    
    
    
89. CHEN Y, Li Y, Wu M, Li Z, et al
    Electroacupuncture improves cognitive function in APP/PS1 mice by inhibiting oxidative stress related hippocampal neuronal ferroptosis.
    Brain Res. 2024;1831:148744.
    PubMed     Abstract available
    
    
    
90. FU Y, Xie GM, Liu RQ, Xie JL, et al
    From aberrant neurodevelopment to neurodegeneration: Insights into the hub gene associated with autism and alzheimer's disease.
    Brain Res. 2024;1838:148992.
    PubMed    
    
    
    
91. CHANG CJ, Taoufiq Z, Yamada H, Kohji T, et al
    The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer's disease model mice.
    Brain Res. 2024 May 6:148987. doi: 10.1016/j.brainres.2024.148987.
    PubMed     Abstract available
    
    
    
92. PEI MQ, Xu LM, Yang YS, Chen WC, et al
    Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders.
    Brain Res. 2024;1830:148821.
    PubMed     Abstract available
    
    
    
93. HE R, Al-Tamimi J, Sanchez-Benavides G, Montana-Valverde G, et al
    Atypical cortical hierarchy in Abeta-positive older adults and its reflection in spontaneous speech.
    Brain Res. 2024;1830:148806.
    PubMed     Abstract available
    
    
    April 2024
94. FOROUGHI S, Shahanipour K, Monajemi R, Ahadi AM, et al
    Investigating the effects of Thymus vulgaris essential oil, Allium cepa extract, and their active compounds (thymol and quercetin) on expression profile of genes related to Alzheimer's disease in PC12 model cell.
    Brain Res. 2024 Apr 28:148966. doi: 10.1016/j.brainres.2024.148966.
    PubMed     Abstract available
    
    
    
95. NEFODOVA A, Rudyk M, Dovhyi R, Dovbynchuk T, et al
    Systemic inflammation in Abeta(1-40)-induced Alzheimer's disease model: New translational opportunities.
    Brain Res. 2024;1837:148960.
    PubMed     Abstract available
    
    
    
96. XIE Y, Li X, Shi Q, Le L, et al
    The synergistic effect of curcumin and mitoquinol mesylate on cognitive impairment and the neuropathology of Alzheimer's disease.
    Brain Res. 2024;1837:148959.
    PubMed     Abstract available
    
    
    
97. BEIYU Z, Rong Z, Yi Z, Shan W, et al
    Oxidative stress is associated with Abeta accumulation in chronic sleep deprivation model.
    Brain Res. 2024;1829:148776.
    PubMed     Abstract available
    
    
    
98. CLELAND NRW, Potter GJ, Buck C, Quang D, et al
    Altered metabolism and DAM-signatures in female brains and microglia with aging.
    Brain Res. 2024;1829:148772.
    PubMed     Abstract available
    
    
    
99. HAN L, Chen W, Li J, Zhao Y, et al
    Palmatine improves cognitive dysfunction in Alzheimer's disease model rats through autophagy pathway and regulation of gut microbiota.
    Brain Res. 2024;1835:148932.
    PubMed     Abstract available
    
    
    
100. UCHIUMI O, Zou J, Yamaki S, Hori Y, et al
     Disruption of sphingomyelin synthase 2 gene alleviates cognitive impairment in a mouse model of Alzheimer's disease.
     Brain Res. 2024;1835:148934.
     PubMed     Abstract available
     
     
     
101. YANG Y, Jia X, Yang X, Wang J, et al
     Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
     Brain Res. 2024;1835:148920.
     PubMed     Abstract available
     
     
     
102. REZAUL ISLAM M, Akash S, Murshedul Islam M, Sarkar N, et al
     Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights.
     Brain Res. 2024 Apr 4:148886. doi: 10.1016/j.brainres.2024.148886.
     PubMed     Abstract available
     
     
     
103. KUSHAWAHA SK, Ashawat MS, Soni D, Kumar P, et al
     Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer's disease.
     Brain Res. 2024;1834:148906.
     PubMed     Abstract available
     
     
     March 2024
104. KAUR K, Kulkarni YA, Wairkar S
     Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems.
     Brain Res. 2024;1834:148905.
     PubMed     Abstract available
     
     
     
105. ANSARI MA, Al-Jarallah A, Rao MS, Babiker A, et al
     Upregulation of NADPH-oxidase, inducible nitric oxide synthase and apoptosis in the hippocampus following impaired insulin signaling in the rats: Development of sporadic Alzheimer's disease.
     Brain Res. 2024;1834:148890.
     PubMed     Abstract available
     
     
     
106. GENG C, Tan L, Chenchen
     Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
     Brain Res. 2024 Mar 20:148881. doi: 10.1016/j.brainres.2024.148881.
     PubMed     Abstract available
     
     
     
107. WANG Y, Song C, Yin G, Meng Y, et al
     Alleviation of behavioral deficits, amyloid-beta deposition, and mitochondrial structure damage associated with mitophagy upregulation in AD animal models via AAV9-IGF-1 treatment.
     Brain Res. 2024;1827:148743.
     PubMed     Abstract available
     
     
     
108. LIU R, Guo L, Zhao Y, Wu D, et al
     Study on multi-target effects of the novel HDAC6 inhibitor W5 on Abeta/Cu(2+)-induced Alzheimer's disease model of rats.
     Brain Res. 2024;1832:148847.
     PubMed     Abstract available
     
     
     
109. MERCERON-MARTINEZ D, Alacan Ricardo L, Bejerano Pina A, Orama Rojo N, et al
     Amylovis-201 enhances physiological memory formation and rescues memory and hippocampal cell loss in a streptozotocin-induced Alzheimer's disease animal model.
     Brain Res. 2024 Mar 1:148848. doi: 10.1016/j.brainres.2024.148848.
     PubMed     Abstract available
     
     
     February 2024
110. WANG W, Zheng WQ, Du X, Chen SC, et al
     Chronic pain exacerbates memory impairment and pathology of Abeta and tau by upregulating IL-1beta and p-65 signaling in a mouse model of Alzheimer's disease.
     Brain Res. 2024 Feb 29:148843. doi: 10.1016/j.brainres.2024.148843.
     PubMed     Abstract available
     
     
     
111. ZHANG Z, Ding C, Fu R, Wang J, et al
     Low-frequency rTMS modulated the excitability and high-frequency firing in hippocampal neurons of the Alzheimer's disease mouse model.
     Brain Res. 2024 Feb 24:148822. doi: 10.1016/j.brainres.2024.148822.
     PubMed     Abstract available
     
     
     
112. PUMO A, Legeay S
     The dichotomous activities of microglia: A potential driver for phenotypic heterogeneity in Alzheimer's disease.
     Brain Res. 2024 Feb 21:148817. doi: 10.1016/j.brainres.2024.148817.
     PubMed     Abstract available
     
     
     
113. MANTELLATTO GRIGOLI M, Pelegrini LNC, Whelan R, Cominetti MR, et al
     Present and Future of Blood-Based Biomarkers of Alzheimer's Disease: Beyond the Classics.
     Brain Res. 2024;1830:148812.
     PubMed     Abstract available
     
     
     
114. SHARMA M, Pal P, Gupta SK
     The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons.
     Brain Res. 2024;1829:148797.
     PubMed     Abstract available
     
     
     
115. DHEVII MANOHARAN S, Abdul Hamid H, Fariesha Md Hashim N, Singh Cheema M, et al
     Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
     Brain Res. 2024 Feb 1:148793. doi: 10.1016/j.brainres.2024.148793.
     PubMed     Abstract available
     
     
     January 2024
116. TSAMOU M, Roggen EL
     Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD).
     Brain Res. 2024 Jan 31:148791. doi: 10.1016/j.brainres.2024.148791.
     PubMed     Abstract available
     
     
     
117. LANDIN-ROMERO R, Kumfor F, Ys Lee A, Leyton C, et al
     Clinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing.
     Brain Res. 2024;1829:148777.
     PubMed     Abstract available
     
     
     
118. ZHAI Y, Morihara R, Feng T, Hu X, et al
     Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3/PIM1/NFATc1 axis, in a novel mouse model of Alzheimer's disease with cerebral hypoperfusion.
     Brain Res. 2024 Jan 23:148790. doi: 10.1016/j.brainres.2024.148790.
     PubMed     Abstract available
     
     
     
119. VALIPOUR B, Simorgh S, Mirsalehi M, Moradi S, et al
     Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer's disease rat model.
     Brain Res. 2024;1828:148764.
     PubMed     Abstract available
     
     
     
120. BELVIRANLI M, Okudan N
     Coconut oil ameliorates behavioral and biochemical alterations induced by D-GAL/AlCl(3) in rats.
     Brain Res. 2024;1823:148704.
     PubMed     Abstract available
     
     
     
121. MAJOU D, Dermenghem AL
     Effects of DHA (omega-3 fatty acid) and estradiol on amyloid beta-peptide regulation in the brain.
     Brain Res. 2024;1823:148681.
     PubMed     Abstract available
     
     
     
122. CHEN H, Yang X, Gao Y, Jiang H, et al
     Electroacupuncture ameliorates cognitive impairment in APP/PS1 mouse by modulating TFEB levels to relieve ALP dysfunction.
     Brain Res. 2024;1823:148683.
     PubMed     Abstract available
     
     
     
123. CHEN P, Zhang S, Zhao K, Kang X, et al
     Robustly uncovering the heterogeneity of neurodegenerative disease by using data-driven subtyping in neuroimaging: A review.
     Brain Res. 2024;1823:148675.
     PubMed     Abstract available
     
     
     
124. KEIL J, Kiiski H, Doherty L, Hernandez-Urbina V, et al
     Artificial sharp-wave-ripples to support memory and counter neurodegeneration.
     Brain Res. 2024;1822:148646.
     PubMed     Abstract available
     
     
     December 2023
125. MIAO J, Liu X, Lan J
     40 Hz Electroacupuncture relieves the memory dysfunction of 5xFAD mice by regulating neuronal electrical activity.
     Brain Res. 2023;1821:148576.
     PubMed     Abstract available
     
     
     
126. YANG Y, Wang J, Ni H, Ding H, et al
     Genetic model of selective COX2 inhibition improve learning and memory ability and brain pathological changes in 5xFAD mouse.
     Brain Res. 2023;1821:148566.
     PubMed     Abstract available
     
     
     
127. YU H, Morihara R, Ota-Elliott R, Bian Z, et al
     Injection of exogenous amyloid-beta oligomers aggravated cognitive deficits, and activated necroptosis, in APP23 transgenic mice.
     Brain Res. 2023;1821:148565.
     PubMed     Abstract available
     
     
     
128. WANG X, Gan W, Kang M, Lv C, et al
     Asthma aggravates alzheimer's disease by up-regulating NF- kappaB signaling pathway through LTD4.
     Brain Res. 2023 Dec 11:148711. doi: 10.1016/j.brainres.2023.148711.
     PubMed     Abstract available
     
     
     November 2023
129. AMIR A, Shahid M, Farooq Khan S, Nisar U, et al
     Nicotinic acid modulates microglial TREM-2 gene in Phytohaemagglutinin-Induced in vitro model of Alzheimer's disease like pathology.
     Brain Res. 2023;1824:148686.
     PubMed     Abstract available
     
     
     
130. WANG Y, Gong Q, Pan H, Wang X, et al
     Gardenia jasminoides J. Ellis extract attenuates memory impairment in rats with Alzheimer's disease by suppressing NLRP3 inflammasome.
     Brain Res. 2023;1824:148687.
     PubMed     Abstract available
     
     
     October 2023
131. XIAOMEI L, Tianyuyi F, Erheng C, Li Y, et al
     A rat model established by simulating genetic-environmental interactions recapitulates human Alzheimer's disease pathology.
     Brain Res. 2023 Oct 31:148663. doi: 10.1016/j.brainres.2023.148663.
     PubMed     Abstract available
     
     
     
132. HASHEMI SA, Ghadimi Z, Ghaedi H, Hashemi A, et al
     The effect of eight weeks of aerobic training with vitamin C on the expression pathway of antioxidants in the hippocampus tissue of TMT induced Alzheimer's disease rats.
     Brain Res. 2023 Oct 21:148645. doi: 10.1016/j.brainres.2023.148645.
     PubMed     Abstract available
     
     
     
133. HENRY SM, Kistler SA, Lagani GD, Bartling CRO, et al
     Tight control of the APP-Mint1 interaction in regulating amyloid production.
     Brain Res. 2023;1817:148496.
     PubMed     Abstract available
     
     
     
134. MOAZZAM F, Hatamian-Zarmi A, Ebrahimi Hosseinzadeh B, Khodagholi F, et al
     Preparation and characterization of brain-targeted polymeric nanocarriers (Frankincense-PMBN-lactoferrin) and in-vivo evaluation on an Alzheimer's disease-like rat model induced by scopolamine.
     Brain Res. 2023;1822:148622.
     PubMed     Abstract available
     
     
     
135. MALIK R, Kalra S, Pooja, Singh G, et al
     Antioxidative and neuroprotective potential of Acorus calamus linn. and Cordia dichotoma G. Forst. In Alzheimer's type dementia in rodent.
     Brain Res. 2023 Oct 2:148616. doi: 10.1016/j.brainres.2023.148616.
     PubMed     Abstract available
     
     
     September 2023
136. LIAN X, Zhang X, Chen W, Xue F, et al
     Dexmedetomidine mitigates neuroinflammation in an Alzheimer's disease mouse model via the miR-204-3p/FBXL7 signaling axis.
     Brain Res. 2023 Sep 29:148612. doi: 10.1016/j.brainres.2023.148612.
     PubMed     Abstract available
     
     
     
137. ASAMU MO, Oladipo OO, Abayomi OA, Adebayo AA, et al
     Alzheimer's disease: The role of T lymphocytes in neuroinflammation and neurodegeneration.
     Brain Res. 2023 Sep 19:148589. doi: 10.1016/j.brainres.2023.148589.
     PubMed     Abstract available
     
     
     
138. ARULCHELVAN E, Vanneste S
     Promising neurostimulation routes for targeting the hippocampus to improve episodic memory: A review.
     Brain Res. 2023;1815:148457.
     PubMed     Abstract available
     
     
     August 2023
139. WANG Y, Shen Z, Wu H, Yu Z, et al
     Identification of genes related to glucose metabolism and analysis of the immune characteristics in Alzheimer's disease.
     Brain Res. 2023 Aug 22:148545. doi: 10.1016/j.brainres.2023.148545.
     PubMed     Abstract available
     
     
     
140. MISHRA M, Raik S, Rattan V, Bhattacharyya S, et al
     Mitochondria transfer as a potential therapeutic mechanism in Alzheimer's disease-like pathology.
     Brain Res. 2023 Aug 22:148544. doi: 10.1016/j.brainres.2023.148544.
     PubMed    
     
     
     
141. ADEKUNLE BABALOLA J, Lang M, George M, Stracke A, et al
     Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.
     Brain Res. 2023 Aug 12:148518. doi: 10.1016/j.brainres.2023.148518.
     PubMed     Abstract available
     
     
     
142. QIN Y, Bai D, Tang M, Zhang M, et al
     Ketogenic diet alleviates brain iron deposition and cognitive dysfunction via Nrf2-mediated ferroptosis pathway in APP/PS1 mouse.
     Brain Res. 2023;1812:148404.
     PubMed     Abstract available
     
     
     June 2023
143. CHAVAN RS, Supalkar KV, Sadar SS, Vyawahare NS, et al
     ANIMAL MODELS OF ALZHEIMER'S DISEASE: AN ORIGINOF INNOVATIVETREATMENTS AND INSIGHT TO THE DISEASE'S ETIOLOGY.
     Brain Res. 2023 Jun 9:148449. doi: 10.1016/j.brainres.2023.148449.
     PubMed     Abstract available
     
     
     
144. KOSE S, Kutlu MD, Kara S, Polat S, et al
     Investigation of the protective effect of long-term exercise on molecular pathways and behaviours in scopolamine induced alzheimer's disease-like condition.
     Brain Res. 2023 Jun 1:148429. doi: 10.1016/j.brainres.2023.148429.
     PubMed     Abstract available
     
     
     May 2023
145. HASAN SMN, Clarke C, Strand T, Bambico FR, et al
     Putative pathological mechanisms of late-life depression and Alzheimer's disease.
     Brain Res. 2023;1813:148423.
     PubMed     Abstract available
     
     
     April 2023
146. CORIA-LUCERO C, Castro A, Ledezma C, Leporatti J, et al
     An intracerebroventricular injection of ABeta (1-42) modifies temporal profiles of spatial memory performance and oxidative status in the temporal cortex rat.
     Brain Res. 2023;1804:148242.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.